论文部分内容阅读
在肾血管性高血压(RVH)的处理甲,究竟手术还是药物治疗好,不断有争论,主要由于在评价或介绍各自的治疗时,未曾建立一致的标准,故重点在于比较药物治疗和手术处理的评价,以及探讨外科的危险性和好处。手术治疗成功的预估有关RVH手术治疗的作用,多数争论涉及手术危险性、手术失败的频率和对术后控制血压的低率。从悲观的观点来看,则仅少数患者能获得手术治疗,手术危险为13%,血管重建术失败率超过20%,
In the treatment of renovascular hypertension (A), whether surgery or drug treatment is good and controversial is mainly due to the fact that no consistent standard has been established in the evaluation or introduction of the respective treatment, the emphasis is on comparison of medical treatment and surgical treatment Evaluation, and discuss the dangers and benefits of surgery. Surgical Treatment Predictions Regarding the Role of RVH Surgical Treatment Most controversies involve the risk of surgery, the frequency of surgical failures, and the rate of postoperative controlled blood pressure. From a pessimistic point of view, only a small number of patients were treated surgically, with a 13% risk of surgery, a failure rate of more than 20% for revascularization,